The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry
Open accessAbstract
Herpes simplex virus type‐1 and type‐2 are highly prevalent human pathogens causing life‐long infections. The process of infection begins when the virions bind heparan sulfate moieties present on host cell surfaces. This initial attachment then triggers a cascade of molecular interactions involving multiple viral and host cell proteins and receptors, leading to penetration of the viral nucleocapsid and tegument proteins into the cytoplasm. The nucleocapsid is then transported to the nuclear membrane and the viral DNA is released for replication in the nucleus. Recent studies have revealed that herpes simplex virus entry or penetration into cells may be a highly complex process and the mechanism of entry may demonstrate unique cell‐type specificities. Although specificities clearly exist, past and ongoing studies demonstrate that herpes simplex virus may share certain common receptors and pathways that are also used by many other human viruses. This minireview helps to shed light on recent revelations on the herpes simplex virus entry process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herpes simplex virus infections
Whitley, R. J., & Roizman, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04638-9 · Cited by 1,391
A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., ROSENBERG, R. D., & Spear, P. G. (1999) · Cell · doi:10.1016/s0092-8674(00)80058-6 · Cited by 1,053
Self-citationRegulated Diversity of Heparan Sulfate*
Lindahl, U., Kusche-Gullberg, M., & Kjellén, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.24979 · Cited by 688
Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus
Sodeik, B., Ebersold, M. W., & Helenius, A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.5.1007 · Cited by 687
Herpes simplex virus: receptors and ligands for cell entry
Spear, P. G. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00389.x · Cited by 582
Crystal Structure of Glycoprotein B from Herpes Simplex Virus 1
Heldwein, E. E. Z., Lou, H., Bender, F. C., Cohen, G. H., Eisenberg, R. J., & Harrison, S. C. (2006) · Science · doi:10.1126/science.1126548 · Cited by 563
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13799 · Cited by 497
Self-citationActin- and myosin-driven movement of viruses along filopodia precedes their entry into cells
Lehmann, M. J., Sherer, N. M., Marks, C. B., Pypaert, M., & Mothes, W. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503059 · Cited by 403
Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor HveA
Carfı́, A., Willis, S. H., Whitbeck, J. C., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., & Wiley, D. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00298-2 · Cited by 391
Nimmerjahn, F., Milosevic, S., Behrends, U., Jaffee, E. M., Pardoll, D. M., Bornkamm, G. W., & Mautner, J. (2003) · European Journal of Immunology · doi:10.1002/eji.200323730 · Cited by 359
Research works printed but not linked: 1
- 10.1172/JCI200113799 · DOI
Cited by
Sorted by citations
Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
Lang, J., Yang, N., Deng, J., Liu, K., Yang, P., Zhang, G., & Jiang, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023710 · Cited by 429
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
Cagno, V., Tseligka, E. D., Jones, S. T., & Tapparel, C. (2019) · Viruses · doi:10.3390/v11070596 · Cited by 393
Recognition of herpesviruses by the innate immune system
Paludan, S. R., Bowie, A., Horan, K., & Fitzgerald, K. A. (2011) · Nature reviews. Immunology · doi:10.1038/nri2937 · Cited by 353
Pharmacology of Heparin and Related Drugs
Mulloy, B., Hogwood, J., Gray, E., Lever, R., & Page, C. P. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.011247 · Cited by 355
Herpes Virus Fusion and Entry: A Story with Many Characters
Eisenberg, R. J., Atanasiu, D., Cairns, T. M., Gallagher, J. R., Krummenacher, C., & Cohen, G. H. (2012) · Viruses · doi:10.3390/v4050800 · Cited by 318
Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9
Shen, S., Bryant, K. D., Brown, S. M., Randell, S. H., & Asokan, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210922 · Cited by 297
Role of Lipids in Virus ReplicationPreprint
Lorizate, M., & Kräusslich, H. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004820 · Cited by 286
Johnson, K. E., Chikoti, L., & Chandran, B. (2013) · Journal of Virology · doi:10.1128/jvi.00082-13 · Cited by 271
The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
Steinberg, M. W., Cheung, T. C., & Ware, C. F. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01064.x · Cited by 252
Orłowski, P., Tomaszewska, E., Gniadek, M., Bąska, P., Nowakowska, J., Sokołowska, J., Nowak, Z., Donten, M., Celichowski, G., Grobelny, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104113 · Cited by 212
Virostatic potential of micro–nano filopodia-like ZnO structures against herpes simplex virus-1
Mishra, Y. K., Adelung, R., Röhl, C., Shukla, D., Spors, F., & Tiwari, V. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.08.017 · Cited by 209
Self-citationBourgade, K., Garneau, H., Giroux, G., Le Page, A. Y., Bocti, C., Dupuis, G., Frost, E. H., & Fülöp, T. (2015) · Biogerontology · doi:10.1007/s10522-014-9538-8 · Cited by 208
Antoine, T. E., Mishra, Y. K., Trigilio, J., Tiwari, V., Adelung, R., & Shukla, D. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.09.020 · Cited by 195
Self-citationHu, Y., Lin, S., Huang, C., Zulueta, M. M. L., Liu, J.-Y., Chang, W., & Hung, S. (2011) · Nature Chemistry · doi:10.1038/nchem.1073 · Cited by 192
Cell Entry Mechanisms of HSV: What we have Learned in Recent Years
Agelidis, A. M., & Shukla, D. (2015) · Future Virology · doi:10.2217/fvl.15.85 · Cited by 191
Self-citationHerpes Simplex Virus Cell Entry Mechanisms: An Update
Madavaraju, K., Koganti, R., Volety, I., Yadavalli, T., & Shukla, D. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.617578 · Cited by 194
Self-citationPhosphatidylserine receptors: Enhancers of enveloped virus entry and infection
Møller-Tank, S., & Maury, W. J. (2014) · Virology · doi:10.1016/j.virol.2014.09.009 · Cited by 192
Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry
Mercer, J., Knébel, S., Schmidt, F. I., Crouse, J., Tait‐Burkard, C., & Helenius, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004618107 · Cited by 171
Herpes simplex virus infects most cell types in vitro: clues to its success
Karasneh, G. A., & Shukla, D. (2011) · Virology Journal · doi:10.1186/1743-422x-8-481 · Cited by 165
Self-citationThe Interplay between Adeno-Associated Virus and Its Helper Viruses
Meier, A. F., Fraefel, C., & Seyffert, M. (2020) · Viruses · doi:10.3390/v12060662 · Cited by 176
Neonatal Herpes Simplex Virus Infection
James, S. H., & Kimberlin, D. W. (2014) · Clinics in Perinatology · doi:10.1016/j.clp.2014.10.005 · Cited by 158
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
Pécheur, E., Borisevich, V., Halfmann, P., Morrey, J. D., Smee, D. F., Prichard, M. N., Mire, C. E., Kawaoka, Y., Geisbert, T. W., & Polyak, S. J. (2016) · Journal of Virology · doi:10.1128/jvi.02077-15 · Cited by 158
Auriti, C., Rose, D. U. D., Santisi, A., Martini, L., Piersigilli, F., Bersani, I., Ronchetti, M. P., & Caforio, L. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166198 · Cited by 162
Nanostructures for the Inhibition of Viral Infections
Szunerits, S., Barras, A., Khanal, M., Pagneux, Q., & Boukherroub, R. (2015) · Molecules · doi:10.3390/molecules200814051 · Cited by 133
Nanomedicine as an emerging approach against intracellular pathogens
Li, B., & Armstead (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s27285 · Cited by 130
Tiwari, V., Darmani, N. A., Yue, B. Y. J. T., & Shukla, D. (2009) · Phytotherapy Research · doi:10.1002/ptr.3085 · Cited by 125
Self-citationGescher, K., Hensel, A., Hafezi, W., Derksen, A., & Kühn, J. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.10.007 · Cited by 118
Neonatal Herpes Simplex Virus Infection
James, S. H., & Kimberlin, D. W. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.05.001 · Cited by 116
Nanoparticles in Antiviral Therapy
Milovanović, M., Arsenijević, A., Milovanović, J., Kanjevac, T., & Arsenijević, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52733-0.00014-8 · Cited by 118
Anti-heparan Sulfate Peptides That Block Herpes Simplex Virus Infection in Vivo
Tiwari, V., Liu, J., Vályi-Nagy, T., & Shukla, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.201103 · Cited by 107
Self-citationWatterson, D., Kobe, B., & Young, P. R. (2011) · Journal of General Virology · doi:10.1099/vir.0.037317-0 · Cited by 106
Exploitation of Cytoskeletal Networks during Early Viral Infection
Walsh, D., & Naghavi, M. H. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.06.008 · Cited by 103
Glycosylation of viral proteins: Implication in virus–host interaction and virulence
Feng, T., Zhang, J., Chen, Z., Pan, W., Chen, Z., Yan, Y., & Dai, J. (2022) · Virulence · doi:10.1080/21505594.2022.2060464 · Cited by 110
Mother-to-Child Transmission of Herpes Simplex Virus
James, S. H., Sheffield, J. S., & Kimberlin, D. W. (2014) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piu050 · Cited by 100
Ron‐Doitch, S., Sawodny, B., Kühbacher, A., David, M. M. N., Samanta, A., Phopase, J., Burger‐Kentischer, A., Griffith, M., Golomb, G., & Rupp, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.025 · Cited by 100
Melissa officinalis Extract Inhibits Attachment of Herpes Simplex Virus in vitro
Astani, A., Reichling, J., & Schnitzler, P. (2012) · Chemotherapy · doi:10.1159/000335590 · Cited by 98
Anti-Viral Properties of Amyloid-β Peptides
Bourgade, K., Dupuis, G., Frost, E. H., & Fülöp, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160517 · Cited by 97
A New Class of Synthetic Peptide Inhibitors Blocks Attachment and Entry of Human Pathogenic Viruses
Krepstakies, M., Lucifora, J., Nagel, C., Zeisel, M. B., Holstermann, B., Hohenberg, H., Kowalski, I., Gutsmann, T., Baumert, T. F., Brandenburg, K., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis273 · Cited by 92
Potential of carbohydrate‐binding agents as therapeutics against enveloped viruses
François, K. O., & Balzarini, J. M. (2010) · Medicinal Research Reviews · doi:10.1002/med.20216 · Cited by 90
Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections
Koganti, R., Yadavalli, T., & Shukla, D. (2019) · Microorganisms · doi:10.3390/microorganisms7100429 · Cited by 81
Self-citationHeparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2
Pasquale, V. D., Quiccione, M. S., Tafuri, S., Avallone, L., & Pavone, L. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126574 · Cited by 85
de Oliveira, A. P., Adams, S. D., Lee, L. H., Murray, S. R., Hsu, S., Hammond, J. R., Dickinson, D. P., Chen, P., & Chu, T.-C. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.11.006 · Cited by 80
Role of Microvesicles in the Spread of Herpes Simplex Virus 1 in Oligodendrocytic Cells
Bello-Morales, R., Praena, B., de la Nuez, C., Rejas, M. T., Guerra, M., Galán-Ganga, M., Izquierdo, M., Calvo, V., Krummenacher, C., & López‐Guerrero, J. A. (2018) · Journal of Virology · doi:10.1128/jvi.00088-18 · Cited by 79
Extracellular Vesicles in Viral Spread and Antiviral Response
Bello‐Morales, R., Ripa, I., & López‐Guerrero, J. A. (2020) · Viruses · doi:10.3390/v12060623 · Cited by 76
Entry of Herpesviruses into Cells: The Enigma Variations
Krummenacher, C., Carfı́, A., Eisenberg, R. J., & Cohen, G. H. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-7651-1_10 · Cited by 73
Imaging Lysosomal pH Alteration in Stressed Cells with a Sensitive Ratiometric Fluorescence Sensor
Xue, Z., Zhao, H., Liu, J., Han, J., & Han, S. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00035 · Cited by 73
Membrane Protein of Human Coronavirus NL63 Is Responsible for Interaction with the Adhesion Receptor
Naskalska, A., Dąbrowska, A., Szczepański, A., Milewska, A., Jasik, K. P., & Pyrć, K. (2019) · Journal of Virology · doi:10.1128/jvi.00355-19 · Cited by 72
Biology and pathogenesis of cytomegalovirus in periodontal disease
Contreras, A., Botero, J. E., & Slots, J. (2013) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00448.x · Cited by 71
Arleevskaya, M., Kravtsova, O., Lemerle, J., Renaudineau, Y., & Tsibulkin, A. P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01296 · Cited by 66
Gescher, K., Kühn, J., Lorentzen, E. U., Hafezi, W., Derksen, A., Deters, A. M., & Hensel, A. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.12.038 · Cited by 68
Evasion of Early Antiviral Responses by Herpes Simplex Viruses
Suazo, P. A., Ibañez, F. J., Retamal-Díaz, A. R., Paz-Fiblas, M. V., Bueno, S. M., Kalergis, A. M., & González, P. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/593757 · Cited by 71
Syndecan receptors: pericellular regulators in development and inflammatory disease
Gopal, S., Arokiasamy, S., Pataki, C. A., Whiteford, J. R., & Couchman, J. (2021) · Open Biology · doi:10.1098/rsob.200377 · Cited by 68
Cerqueira, C., Liu, Y., Kühling, L., Chai, W., Hafezi, W., Kuppevelt, T. H. V., Kühn, J., Feizi, T., & Schelhaas, M. (2013) · Cellular Microbiology · doi:10.1111/cmi.12150 · Cited by 64
Genital Herpes: Insights into Sexually Transmitted Infectious Disease
Jaishankar, D., & Shukla, D. (2016) · Microbial Cell · doi:10.15698/mic2016.09.528 · Cited by 66
Self-citationAggarwal, A., Saksena, M. M., Boadle, R. A., Kelly, B., Diefenbach, R. J., Alam, W., & Cunningham, A. L. (2012) · Journal of Virology · doi:10.1128/jvi.07016-11 · Cited by 63
Rajtar, B., Skalicka‐Woźniak, K., Świątek, Ł., Stec, A., Boguszewska, A., & Polz‐Dacewicz, M. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.05.011 · Cited by 63
Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease?
Naqvi, A. R., Shango, J., Seal, A., Shukla, D., & Nares, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02099 · Cited by 63
Self-citationXu, X., Zhang, Y., & Li, Q. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2054 · Cited by 66
Cheng, A. Z., Moraes, S. N., Attarian, C., Yockteng-Melgar, J., Jarvis, M. C., Biolatti, M., Galitska, G., Dell’Oste, V., Frappier, L., Bierle, C. J., et al. (2019) · Journal of Virology · doi:10.1128/jvi.01539-19 · Cited by 66
Glycoprotein targeted therapeutics: a new era of anti‐herpes simplex virus‐1 therapeutics
Antoine, T. E., Park, P. J., & Shukla, D. (2013) · Reviews in Medical Virology · doi:10.1002/rmv.1740 · Cited by 60
Self-citationDrug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery
Yadavalli, T., Ames, J. M., Agelidis, A. M., Suryawanshi, R. K., Jaishankar, D., Hopkins, J., Thakkar, N., Koujah, L., & Shukla, D. (2019) · Science Advances · doi:10.1126/sciadv.aax0780 · Cited by 60
Self-citationRevisiting Regulated Cell Death Responses in Viral Infections
Balaya, R. D. A., Prasad, T. S. K., & Kandasamy, R. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137023 · Cited by 60
Tiwari, V., & Shukla, D. (2010) · Journal of General Virology · doi:10.1099/vir.0.024166-0 · Cited by 59
Self-citationRedwan, E. M. M. M., El‐Fakharany, E. M., Uversky, V. N., & Linjawi, M. H. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-219 · Cited by 59
HSV ‐1 Glycoproteins Are Delivered to Virus Assembly Sites Through Dynamin‐Dependent Endocytosis
Albecka, A., Laine, R. F., Janssen, A. F. J., Kaminski, C. F., & Crump, C. M. (2015) · Traffic · doi:10.1111/tra.12340 · Cited by 57
Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection
Menendez, C. M., & Carr, D. J. J. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.02.020 · Cited by 60
Extracellular matrix in plants and animals: hooks and locks for viruses
Stavolone, L., & Lionetti, V. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01760 · Cited by 59
Badr, G., Ramadan, N. K., Sayed, L. H., Badr, B. M., Omar, H. E.-D. M., & Selamoğlu, Z. (2017) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.8573 · Cited by 58
Herpes Simplex Virus Type-1: Replication, Latency, Reactivation and its Antiviral Targets
de Mello, C. P. P., Bloom, D. C., & Paixão, I. C. N. D. P. (2015) · Antiviral Therapy · doi:10.3851/imp3018 · Cited by 56
Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies
Tiwari, V., Tarbutton, M., & Shukla, D. (2015) · Molecules · doi:10.3390/molecules20022707 · Cited by 53
Self-citationEmerging Roles of Heparanase in Viral Pathogenesis
Thakkar, N., Yadavalli, T., Jaishankar, D., & Shukla, D. (2017) · Pathogens · doi:10.3390/pathogens6030043 · Cited by 53
Self-citationExtracellular Vesicles in Herpes Viral Spread and Immune Evasion
Bello‐Morales, R., & López‐Guerrero, J. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02572 · Cited by 53
Su, D., Li-ping, H., Shi, C., Li, Y., Qian, S., Feng, Z., & Yu, L. (2024) · Virulence · doi:10.1080/21505594.2024.2425744 · Cited by 59
Recent advances in vaccine development for herpes simplex virus types I and II
Coleman, J. L., & Shukla, D. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23289 · Cited by 52
Self-citationMatos, P. M., Marin, M., Ahn, B., Lam, W. A., Santos, N. C., & Melikyan, G. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.462028 · Cited by 52
Neonatal herpes simplex virus infection: From the maternal infection to the child outcome
Rose, D. U. D., Bompard, S., Maddaloni, C., Bersani, I., Martini, L., Santisi, A., Longo, D., Ronchetti, M. P., Dotta, A., & Auriti, C. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29024 · Cited by 51
Cytotoxic, Virucidal, and Antiviral Activity of South American Plant and Algae Extracts
Faral‐Tello, P., Mirazo, S., Dutra, C., Parada, A. P., Geis‐Asteggiante, L., Frabasile, S., Koncke, E., Davyt, D., Cavallaro, L. V., Heinzen, H., et al. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/174837 · Cited by 51
Batista, F. M., López-Sanmartín, M., Grade, A., Morgado, I. M., Valente, M., Navas, J. I., Power, D. M., & Ruano, F. (2014) · Aquaculture · doi:10.1016/j.aquaculture.2014.09.016 · Cited by 48
Diverse Functions of Glycosaminoglycans in Infectious Diseases
Aquino, R. S., Lee, E. S., & Park, P. W. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)93016-0 · Cited by 49
Mediators and Mechanisms of Herpes Simplex Virus Entry into Ocular Cells
Farooq, A. V., Vályi-Nagy, T., & Shukla, D. (2010) · Current Eye Research · doi:10.3109/02713681003734841 · Cited by 48
Self-citationMuñoz‐Fernández, M. Á., Diez, R. C., Vacas‐Córdoba, E., García‐Broncano, P., de la Mata, F. J., Gómez, R., & Maly, M. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s95301 · Cited by 47
Sharma, D., Sharma, S., Akojwar, N., Dondulkar, A., Yenorkar, N. Y., Pandita, D., Prasad, S. K., & Dhobi, M. (2023) · Vaccines · doi:10.3390/vaccines11020206 · Cited by 45
Contribution of N-linked glycans on HSV-2 gB to cell–cell fusion and viral entry
Luo, S., Hu, K., He, S., Wang, P., Zhang, M., Huang, X., Du, T., Zheng, C., Liu, Y., & Hu, Q. (2015) · Virology · doi:10.1016/j.virol.2015.04.005 · Cited by 45
Jaishankar, D., Buhrman, J. S., Vályi-Nagy, T., Gemeinhart, R. A., & Shukla, D. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18365 · Cited by 45
Self-citationClinical Management of Herpes Simplex Virus Keratitis
Labib, B. A., & Chigbu, D. I. (2022) · Diagnostics · doi:10.3390/diagnostics12102368 · Cited by 44
Tannic acid modification of metal nanoparticles: possibility for new antiviral applications
Krzyżowska, M., Tomaszewska, E., Ranoszek‐Soliwoda, K., Bień, K., Orłowski, P., Celichowski, G., & Grobelny, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47720-8.00013-4 · Cited by 44
Zebrafish: Modeling for Herpes Simplex Virus Infections
Antoine, T. E., Jones, K. S., Dale, R. M., Shukla, D., & Tiwari, V. (2013) · Zebrafish · doi:10.1089/zeb.2013.0920 · Cited by 43
Self-citationBasal Autophagy Is Required for Herpes simplex Virus-2 Infection
Yakoub, A. M., & Shukla, D. (2015) · Scientific Reports · doi:10.1038/srep12985 · Cited by 44
Self-citationVallbracht, M., Backović, M., Klupp, B. G., Rey, F. A., & Mettenleiter, T. C. (2019) · Advances in virus research · doi:10.1016/bs.aivir.2019.05.007 · Cited by 42
Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress
Hadigal, S. R., Koganti, R., Yadavalli, T., Agelidis, A. M., Suryawanshi, R. K., & Shukla, D. (2019) · Journal of Virology · doi:10.1128/jvi.01672-19 · Cited by 42
Self-citationZhang, M., Liu, Y., Wang, P., Guan, X., He, S., Luo, S., Li, C., Hu, K., Jin, W., Du, T., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401538 · Cited by 42
Wang, Z., Jia, J., Wang, L., Li, F., Wang, Y., Jiang, Y., Song, X., Qin, S., Zheng, K., Ye, J., et al. (2020) · Virology Journal · doi:10.1186/s12985-020-01315-z · Cited by 41
Oncolytic Herpes Simplex Viruses as a Paradigm for the Treatment of Cancer
Bommareddy, P. K., Peters, C. W., Saha, D., Rabkin, S. D., & Kaufman, H. L. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050254 · Cited by 42
Skin Viral Infections: Host Antiviral Innate Immunity and Viral Immune Evasion
Lei, V., Petty, A. J., Atwater, A. R., Wolfe, S. A., & MacLeod, A. S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.593901 · Cited by 45
Kumar, B., Dutta, D., Iqbal, J., Ansari, M. A., Roy, A., Leela, C., Pisano, G., Veettil, M. V., & Chandran, B. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005960 · Cited by 39
Effect of black tea extract on herpes simplex virus-1 infection of cultured cells
Cantatore, A., Randall, S. D., Traum, D., & Adams, S. D. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-139 · Cited by 40
Natural bioactive compounds from marine fungi (2017–2020)
Wang, H., Sun, S., Liu, M., Yan, M., Liu, Y.-F., Zhu, Z., & Zhang, Z. (2021) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2021.1947254 · Cited by 39
Role of L-Particles during Herpes Simplex Virus Infection
Heilingloh, C. S., & Krawczyk, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02565 · Cited by 38
Initial Contact: The First Steps in Herpesvirus Entry
Azab, W., & Osterrieder, N. (2017) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-53168-7_1 · Cited by 38
Sharma, V., Mobeen, F., & Prakash, T. (2016) · International Journal of Genomics · doi:10.1155/2016/9543274 · Cited by 36
Metadata
- Authors
- Akhtar, J., & Shukla, D.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Shukla, Deepak
- ORCID
- Shukla, Deepak
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2009-11-27
- Volume
- 276
- Issue
- 24
- Pages
- 7228-7236
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- PMC
- PMC2801626
- OpenAlex
- W1501808502
- Cited by
- 292
- References
- 48
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 17 · 2023: 15 · 2022: 17 · 2021: 18 · 2020: 19 · 2019: 14 · 2018: 18 · 2017: 23 · 2016: 23 · 2015: 21 · 2014: 20 · 2013: 17 · 2012: 20
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- FEBS Journal (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Research to Prevent Blindness
- National Institutes of Health
- National Eye Institute (EY 01792, P30EY001792)
- National Institute of Allergy and Infectious Diseases (R01AI057860)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- herpes simplex virus type 1, herpes simplex virus type 2, viral entry, heparan sulfate, viral attachment, tegument proteins, viral DNA replication, cell type specificity, host-virus interaction
- MeSH terms
- Cell Communication, Humans, Membrane Fusion, Membrane Glycoproteins, Pseudopodia, Receptors, Immunologic, Viral Envelope Proteins, Herpesvirus 2, Human, Herpesvirus 1, Human, Heparan Sulfate Proteoglycans, Virus Internalization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review